GSK buys COVID and flu vaccines from shrinking CureVac company

British drugmaker GSK on Wednesday bought out partner CureVac from its alliance to develop influenza vaccines and COVID-19, boosting its RNA informatics expertise and expanding the German biotech company’s financial capabilities.

Share This Post:

POPULAR POSTS
FOLLOW US
Like Us On Facebook
Follow Us On Twitter
Subscribe To Our Channel
TikTok
LIVE STREAM